VENTURE CREATION & ENTREPENEURSHIP
Tuesday, February 17, 15:30 - 16:15
Sam Possemiers | CEO, MRM Health
Sam is a founder and CEO of MRM Health and has 20 years’ expertise in gut microbiome, host-microbiome interactions and immunity at both academic and industrial level. He is an experienced entrepreneur with an extensive commercial network and previously co-founded ProDigest, which he built and led as CEO for 12 years. He also co-founded MRM Technologies, a center of expertise for microbiome R&D, and previously acted as R&D Director of BioActor, a Netherlands-based health ingredient company. He holds a PhD in intestinal microbial ecology from Ghent University, in partnership with the French National Institute for Agricultural Research (INRA) in Paris, France.
About MRM Health
MRM Health is a clinical-stage biotech developing innovative Live Biotherapeutic Products (LBPs) for immune-mediated diseases with high unmet needs. Its CORAL® platform enables the design and manufacture of disease-focused microbial consortia (specific combinations of live bacteria) with enhanced efficacy and scalability. The Company’s lead program, MH002, for inflammatory bowel diseases (IBD) has shown positive Phase 2a clinical data in ulcerative colitis and pouchitis and is now being evaluated in a 204-patient Phase 2b clinical trial across EU and US. MRM Health is expanding its pipeline across other inflammatory diseases and immune-oncology, leveraging AI-guided discovery and deep expertise in microbiome ecosystem biology. In September 2025, MRM Health successfully closed a €55 million Series B round led by Biocodex, with strong support from ATHOS, BNP Paribas Fortis Private Equity and existing investors SFPIM, AvH, OMX Europe VF, QBIC II and VIB.
Learn more at mrmhealth.com
| Powered by: BCF Courses BV | Connect with us | Join BioBusiness Winter School | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | Register |
| © Copyright 2026 by BCF Courses |